Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease

被引：5
|
作者：
Paccou, Julien [1 ]
Nachury, Maria [2 ]
Duchemin, Cedric [1 ]
Desreumaux, Pierre [2 ]
Flipo, Rene-Marc [1 ]
Pariente, Benjamin [2 ]
机构：
[1] CHU Lille, Serv Rhumatol, F-59000 Lille, France
[2] CHU Lille, Serv Gastroenterol, F-59000 Lille, France
来源：
JOINT BONE SPINE | 2019年 / 86卷 / 05期
关键词：
Vedolizumab; Spondyloarthritis; Inflammatory bowel disease; TNF antagonists;
D O I：
10.1016/j.jbspin.2019.01.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：654 / 656
页数：3
相关论文
共 50 条
  • [1] CLINICAL EFFECT OF VEDOLIZUMAB ON ARTICULAR MANIFESTATIONS IN PATIENTS WITH SPONDYLOARTHRITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE
    Paccou, J.
    Nachury, M.
    Duchemin, C.
    Desreumaux, P.
    Flipo, R. -M.
    Pariente, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 64 - 65
  • [2] Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease
    Orlando, Ambrogio
    Orlando, Rosalba
    Ciccia, Francesco
    Renna, Sara
    Rizzo, Aroldo
    Cottone, Mario
    Macaluso, Fabio Salvatore
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (09)
  • [3] Articular Manifestations in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
    Dupre, Anastasia
    Collins, Michael
    Carbonnel, Franck
    Mariette, Xavier
    Seror, Raphaele
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [4] Articular manifestations in patients with inflammatory bowel disease treated with vedolizumab
    Dupre, Anastasia
    Collins, Michael
    Nocturne, Gaetane
    Carbonnel, Franck
    Mariette, Xavier
    Seror, Raphaele
    [J]. RHEUMATOLOGY, 2020, 59 (11) : 3275 - 3283
  • [5] ARTICULAR MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Dupre, Anastasia
    Collins, Michael
    Carbonnel, Franck
    Mariette, Xavier
    Nocturne, Gaetane
    Seror, Raphaele
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1240 - 1241
  • [6] Response to: 'Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease' by Orlando et al
    Varkas, G.
    Van den Bosch, F.
    Elewaut, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (09)
  • [7] MUSCULOSKELETAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Rodriguez-Merlos, P.
    Ruiz-Ramirez, M. A.
    Plasencia, C.
    Navarro-Compan, V.
    Suarez-Ferrer, C.
    Martin-Arranz, E.
    Martin Arranz, M. D.
    Peiteado, D.
    Bonilla, G.
    Sanchez Azofra, M.
    Poza Cordon, J.
    Franco Gomez, K. N.
    Balsa, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 731 - 732
  • [8] The Effect of Vedolizumab on Spondyloarthritis Symptoms in a Cohort of Inflammatory Bowel Disease Patients
    Huseynzada, Sinakhanim
    Inel, Tuba Yuce
    Hajiyev, Farid
    Avsar, Aydan Koken
    Balci, Ali
    Akpinar, Hale
    Onen, Fatos
    Sari, Ismail
    [J]. EUROPEAN JOURNAL OF RHEUMATOLOGY, 2023, 10 (02) : 50 - +
  • [9] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Jurij Hanzel
    Christopher Ma
    Niels Vande Casteele
    Reena Khanna
    Vipul Jairath
    Brian G. Feagan
    [J]. Drugs, 2021, 81 : 333 - 347
  • [10] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Hanzel, Jurij
    Ma, Christopher
    Vande Casteele, Niels
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    [J]. DRUGS, 2021, 81 (03) : 333 - 347
12345